PGY1 Pharmacy Residency 

PGY2 Oncology
Front: Farehaa Hussain, Leeann Williamson, Rachael Kral, Gabrielle Flynn, Roxanne Weatherman
Back: Beth Kernodle, Kendal Newman, Max Herbert, Ethan Nguyen, Hannah McCullough, Maria Arlia

Follow us on social media for updates and more!

Instagram@UVARxResidency
FacebookUVA Pharmacy Residency


Applicant Resources

Application deadline: January 2, 2025

2025-2026 Information Sessions (Eastern Standard Time)

  • Tuesday, September 17th from 6:00 to 6:45 PM 
  • Thursday, October 24th from 8:00 to 8:45 PM
  • Monday, November 18th from 7:00 to 7:45 PM
  • Friday, December 20th from 4:00 to 4:45 PM

Information Session Registration Link

Resident/Contact Person:
Rachael Kral, PharmD


Program Description

Number of positions:
8
How to apply:
Rotation Schedule:
Program information:
Residency Manual
Certifications:

ACLS Training and Certification (required for PGY1)
Teaching and Learning Certificate

Biographies:
 
 
 

Current Residents

Residency Program Director

Residency Program Coordinator

 

2024-2025 Resident Projects

Resident Project Primary Preceptor Project Type
Maria Arlia Addressing re-dispenses of non-controlled, injectable medications due to missing doses Kara Thornton Quality
Max Herbert Antibiotic stewardship at transitions of care Corey Medler Quality
Farehaa Hussain Reduction of post-operative opioid utilization in pediatric surgical patients - a focus on pediatric orthopedic procedures Krissy Bryant Quality
Beth Kernodle Optimization of IV iron use in patients with heart failure with reduced ejection fraction

Emily Burns

Abby Cummings

Quality
Rachael Kral Describing OPAT (Outpatient Parenteral Antibiotic Therapy) service interventions during transitions of care Adam Archer Research
Hannah McCullough Optimization of ethanol withdrawal management Nate Hedrick Quality
Kendal Newman Effects of vitamin K administration in patients with cirrhosis Allison Chidester Research
Ethan Nguyen Evaluation of dexmedetomidine dosed with actual versus adjusted body weight in obese patients Rita Jamil Research
Leeann Williamson Interference of DOACs on anti-Xa levels in patients with ESRD and/or liver disease Jen Walters Research

 

Program Director/Contact Person:
Katelyn Hipwell, PharmD, MPH

Assistant Program Director:
Allison Chidester, PharmD, BCCP